6533b855fe1ef96bd12b1b66

RESEARCH PRODUCT

Clinical outcomes after 3 years of idursulfase treatment in patients with MPS II: data from the Hunter Outcome Survey (HOS)

Virginie JegoMaurizio ScarpaAnna Tylki-szymańskaMichael BeckRoberto GiuglianiJoseph Muenzer

subject

medicine.medical_specialtyIdursulfasebusiness.industryEndocrinology Diabetes and MetabolismBiochemistryOutcome (game theory)EndocrinologyInternal medicineGeneticsmedicineIn patientbusinessMolecular Biologymedicine.drughttps://doi.org/10.1016/j.ymgme.2016.11.123